Trials / Completed
CompletedNCT00264043
The Study to Evaluate Patient Outcome Using Distal Protection Combined With the BX Velocity.
Distal Protection Combined With Velocity in Coronary Arteries and SVBG Registry.
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 100 (actual)
- Sponsor
- Cordis US Corp. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective is to evaluate the use of the AngioGuard™ device combined with the Bx Velocity™ on patient outcome at one month.
Detailed description
This is a prospective, non-randomized, multi-center trial. Patients will be treated with the AngioGuard™ device and Bx Velocity™ stent and will be followed for six-months post-procedure.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | emboli capturing guidewire device combined with stent | AngioGuard™ device and Bx Velocity™ stent |
Timeline
- Start date
- 2000-05-01
- Primary completion
- 2002-02-01
- Completion
- 2002-06-01
- First posted
- 2005-12-12
- Last updated
- 2008-08-06
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00264043. Inclusion in this directory is not an endorsement.